Navigation Links
Mini-pig tale provides massive amount of genomic data for human health
Date:11/14/2012

November 15, 2012, Hong Kong, China The international open-access journal GigaScience (a BGI and BioMed Central journal) announces the publication of the whole-genome sequencing and analysis of the Wuzhishan Pig, an extensively inbred, miniature pig, which can serve as an excellent model for human medical research. The availability of the mini-pig genome provides a wealth of genetic tools that will enable detailed and well thought-out analyses on an animal that shares a substantial number of complex diseases with humans. The work here, led by researchers from the BGI, Beijing Institute of Animal Science (IAS), and Chinese Academy of Agriculture Science (CAAS), also revealed potentially actionable resources including the identification of the porcine counterparts of human drug target genes.

Pigs are one of the oldest domesticated livestock species, and as well as providing one of the largest sources of meat worldwide, also provide important medical industrial resources, such as pharmaceutical-grade heparin and heart valves for xenotransplantation. The pig shares many of the same complex genetic diseases as humans, making them excellent models for studying the underlying biology of human disease. Furthermore, the similarity of the pig diet and digestive system with humans makes them ideal for investigation of metabolic diseases and nutritional analyses. The Wuzhishan pig used in this study provides additional advantages for medical analysis: its small size makes it easy to handle; and its long history of inbreeding have resulted in a breed of pigs made up of individuals that are genetically very similar, allowing greater reproducibility in scientific analyses.

To provide the best understanding of the genetics of the Wuzhishan pig and tools for laboratory studies, the researchers at the BGI in collaboration with scientists from several institutions in China and Denmark, carried out whole genome sequencing. They obtained a genome sequence of exceptionally high quality and used this to assess genomic structure and functional elements and investigate characteristics that would be of great interest for medical studies. In particular they looked at genes and protein domains that were the pig counterpart of human genes that are important for therapeutic drug activity. These analyses showed that the Wuzhishan pig genome contained a very large number of similar drug target genes for several types of human disorders, indicating that this pig would serve as an excellent model for drug testing in these cases. However, the researchers also found that there were several situations where target genes showed important differences from the human versions. This information is of great use as well, as it provides a clear indication of the types of drug testing for which this organism is not as useful, saving unnecessary experimentation, time, and money.

Lead researchers Dr Yutao Du and Prof Shutang Feng note that, "the physiological similarities to humans was maintained at a genetic level with 84% homology between the two species. While there was a great deal of similarity in genes known to be involved in coronary artery disease and drug target genes, detailed analysis showed that there were several important differences which need to be taken account of."

The scientists also assessed the presence of viruses integrated into the genome, which is a concern given that pigs have been considered as a possible source of xenotransplantation and thus viruses could be transferred to the human patients through transplantation.

Drs Du and Feng noted that the viral analyses provide tools and information for investigating such concerns by allowing more direct assessment of the risk of transmission. They explained that, "both humans and pigs carry viruses hidden within their genomes. One particular virus, porcine endogenous retrovirus (PER), once activated can infect human cells, however the genome sequence has revealed that a specific type PER virus (type C) has been lost from the mini-pig."

Overall, the extensive amount of work in this study serves as a springboard for more economical and directed means of carrying out biomedical analyses and also provides a new resource for investigation of economically important traits, domestication events, and the evolution of this group of animals.


'/>"/>

Contact: Scott Edmunds
scott@gigasciencejournal.com
86-755-826-35416
GigaScience
Source:Eurekalert

Related biology news :

1. Study provides recipe for supercharging atoms with X-ray laser
2. Mass extinction study provides lessons for modern world
3. Research provides new insights into dogs natural feeding behavior and finds they target a daily dietary intake that is high in fat
4. Study provides first-time analysis of 3 distinct contributions of forage fish worldwide
5. New method provides fast, accurate, low cost analysis of BRCA gene mutations in breast cancer
6. Yak genome provides new insights into high altitude adaptation
7. Innate immune system protein provides a new target in war against bacterial infections
8. Study provides first evidence of coevolution between invasive, native species
9. New discovery provides insight on long-standing pregnancy mystery
10. Study provides new insights into structure of heart muscle fibers
11. New study by WHOI scientists provides baseline measurements of carbon in Arctic Ocean
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2016)... India , January 21, 2016 ... According to a new market research report "Emotion Detection ... and Others), Software Tools (Facial Expression, Voice Recognition ... Regions - Global forecast to 2020", published by ... is expected to reach USD 22.65 Billion by ...
(Date:1/18/2016)... , Jan. 18, 2016  Extenua Inc., a ... simplifies the use and access of ubiquitous on-premise ... partnership with American Cyber.  ... experience leading transformational C4ISR and Cyber initiatives in ... the latest proven technology solutions," said Steve ...
(Date:1/11/2016)... Jan. 11, 2016 Synaptics Incorporated (NASDAQ: ... today announced that its ClearPad ® TouchView ™ ... won two separate categories in the 8 th ... Best Technology Breakthrough. The Synaptics ® TDDI solution ... supply chain, thinner devices, brighter displays and borderless designs. ...
Breaking Biology News(10 mins):
(Date:2/5/2016)... Feb. 5, 2016  In the pharmaceutical industry the ... host of launch activities including the identification and engagement ... activity is especially high in the oncology therapeutic area ... Practices and the Role of Medical Affairs in Oncology ... on oncology therapies find better ways to utilize medical ...
(Date:2/4/2016)... - New FDA action date of July ... action date of July 22, 2016   --> ... 22, 2016   - Lifitegrast has the ... for the treatment of signs and symptoms of dry eye disease ... to be the only product approved in the U.S. in the past decade indicated for ...
(Date:2/4/2016)... JUNCTION, N.J. , Feb. 4, 2016 /PRNewswire/ ... care immunotherapy leader commercializing its flagship CytoSorb® blood ... cardiac surgery patients around the world, announced that ... will present at the Source Capital Group,s 2016 ... and update on the company.  ...
(Date:2/4/2016)... , Feb. 4, 2016 Sinovac Biotech Ltd. ... leading provider of biopharmaceutical products in China ... its board of directors received on February 4, 2016 ... from a consortium comprised of PKU V-Ming ( ... Co., Ltd., CICC Qianhai Development ( Shenzhen ...
Breaking Biology Technology: